Cosmetic Ingredients
Evaluating the cosmetic applications and market potential of Cephalotaxus callus extract through our Cephalotaxus Cell Relaxing Serum.
Commercialization
Plant cells, Better ingredients, Better future
PhytoRevolution is a biomaterials company
that develops high-value, plant-derived active ingredients
through plant cell culture technology.
Our approach enables
consistent quality and reliable production.
achieving consistent quality and stable production.
By unlocking the bioactive potential of plants and expanding
applications
from cosmetics to pharmaceutical ingredients,
we aim to advance human health, enhance beauty, and improve quality of
life.
Plant Cell-based Active Ingredient (PCAI®) Technology
Plant
Resources
Cell & Tissue
Culture
Scale-up
Bioreactor
Bioactive
Metabolites
Sustainable
Applications
The composition of wild-grown plants varies with environmental conditions and seasonal changes, while repeated harvesting poses challenges to supply stability and sustainability.
PhytoRevolution addresses these challenges through PCAI® technology, establishing stable callus cultures from carefully selected mother plants. This approach supports consistent raw material quality, reproducible production, and sustainable sourcing—unlocking the potential of plant-derived active compounds for use in premium bioactive materials.
Learn more →Pipeline
1. Expanding Our Plant Portfolio
Cephalotaxus
Cephalotaxus harringtonii
Potential anticancer and antiviral properties
Gardenia
Gardenia jasminoides
Potential liver-protective, anti-inflammatory, antioxidant & anti-allergic effects
Chinese Lantern
Physalis alkekengi
Potential to promote collagen synthesis and skin brightening
2. From Plant Cells to Bioactive Materials
Evaluating the cosmetic applications and market potential of Cephalotaxus callus extract through our Cephalotaxus Cell Relaxing Serum.
CommercializationExploring applications in health functional foods, supported by compositional analysis and bioactivity data gathered during ingredient development.
ExpansionExploring development and licensing opportunities for high-value, plant-derived APIs, with a focus on harringtonine and related compounds, to contribute to Korea’s biopharmaceutical industry.
Future PipelineDocumenting Our Journey.
We welcome partnerships in research, ingredient development, and commercialization of Korean native plant cell culture materials.
Contact →2026
2025